The first group was formed of the patients diagnosed hyperemesis gravidarum with dehydration

The control group was formed of the patients who were healthy pregnant women admitted to the clinic just for routine examination without any symptoms

Hyperemesis; Gravidarum, With Dehydration

Kayseri Training and Research Hospital

Endothelial Dysfunction in Hyperemesis Gravidarum

Erdem Sahin

Principal Investigator

Kayseri Education and Research Hospital

Patients on deep brain stimulation for either obsessive-compulsive disorder or major depression, undergoing rechargeable neurostimulator implantation as intervention

Obsessive-compulsive Disorder

Depression

Rechargeable neurostimulators are implanted when the non-rechargeable neurostimulators are end-of-life.

Medtronic Restore Advanced 37713

Rechargeable Neurostimulators in Deep Brain Stimulation for Psychiatric Disorders

Feasibility Study Regarding the Implantation and Use of Rechargeable Neurostimulators in Deep Brain Stimulation for Psychiatric Disorders (Either Obsessive-compulsive Disorder or Major Depression)

Change in mean Yale‐Brown Obsessive Compulsive Scale (Y‐BOCS). Mean Y-BOCS during the first 2 years after intervention minus mean Y-BOCS during the last 2 years before intervention.

Change in Hamilton Depression Rating Scale (HAM‐D). Mean HAM-D during the first 2 years after intervention minus mean HAM-D during the last 2 years before intervention.

Change in Beck Depression Inventory (BDI). Mean BDI during the first 2 years after intervention minus mean BDI during the last 2 years before intervention.

Change in Global Assessment of Functioning (GAF). Mean GAF during the first 2 years after intervention minus mean GAF during the last 2 years before intervention.

Change in Stimulation amplitude as measured in volt. Mean stimulation amplitude during the first 2 years after intervention minus mean stimulation amplitude during the last 2 years before intervention.

Change in Stimulation frequency as measured in hertz Mean stimulation frequency during the first 2 years after intervention minus mean stimulation frequency during the last 2 years before intervention

Stimulation pulse width as measured in seconds. Mean stimulation pulse width during the first 2 years after intervention minus mean stimulation pulse width during the last 2 years before intervention.

Change in stimulation contact configuration as expressed in fraction of patients using a certain contact point as anode or cathode.
Fraction of patients using a certain contact point as cathode or anode during the first 2 years after intervention minus fraction of patients using a certain contact point as cathode or anode during the last 2 years before intervention.

Change in frequency of outpatient clinic contacts at the Psychiatry department. Frequency of outpatient clinic contacts at the Psychiatry department during the first 2 years after intervention minus frequency of outpatient clinic contacts at the Psychiatry department during the last 2 years before intervention.

Change in fraction of hospitalized days at the Psychiatry department. Fraction of hospitalized days at the Psychiatry department during the first 2 years after intervention minus fraction of hospitalized days at the Psychiatry department during the last 2 years before intervention.

Change in frequency of outpatient clinic contacts at the Neurosurgery department.
Frequency of outpatient clinic contacts at the Neurosurgery department during the first 2 years after intervention minus frequency of outpatient clinic contacts at the Neurosurgery department during the last 2 years before intervention.

Change in fraction of hospitalized days at the Neurosurgery department. Fraction of hospitalized days at the Neurosurgery department during the first 2 years after intervention minus fraction of hospitalized days at the Neurosurgery department during the last 2 years before intervention.

Change in frequency of neurosurgical procedures related to the DBS system. Frequency of neurosurgical procedures related to the DBS system after intervention minus frequency of neurosurgical procedures related to the DBS system before intervention.

Universitaire Ziekenhuizen Leuven

Medtronic

End Stage Renal Disease

No intervention

Herlev Hospital

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

Planned dialysis
The patient's first dialysis is planned if:
His first hemodialysis uses an AV fistula
His first hemodialysis uses a permanent catheter as the patient's permanent access
His first peritoneal dialysis is >6 days after catheter placement.
The patient's first dialysis is unplanned if:
His first hemodialysis uses a temporary catheter
His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
His first peritoneal dialysis is <7 days after catheter placement.

AVF, AVG, Temporary CVC, Tunneled CVC, or PD catheter

James heaf

Doctor

Odense University Hospital

Aarhus University Hospital Skejby

Zealand University Hospital

Holbaek Sygehus

Central Jutland Regional Hospital

Sonderborg Hospital

Skovde Hospital

Karolinska University Hospital

Lund University Hospital

Turku University Hospital

Pauls Stradins Clinical University Hospital

Tartu University Hospital

The Hospital of Vestfold

St. Olavs Hospital

Oslo University Hospital

Patients randomized to this arm will receive intravenous ketaprofen when treating renal colic.
Intervention: intravenous ketaprofen

Patients randomized to this arm will receive intravenous paracetamol when treating renal colic.
Intervention: intravenous paracetamol

Renal Colic

Acute Renal Colic

Patients will recieve 100 mg of ketoprofen via slow intravenous perfusion. (100mg of ketoprofen powder for injection dissolved in 100 ml injectable isotonic solution)

Intravenous ketoprofen

Patients will receive 1g of paracetamol via slow intravenous perfusion. (100 ml of solution at 10mg/ml)

Intravenous paracetamol

CH d'Alès

CHU de Nîmes - Hôpital Universitaire Carémeau

Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations

Comparing the Efficacy of Intravenous Paracetamol and Ketoprofen When Treating Renal Colic in Emergency Situations: a Randomized, Bi-centric, Double-blind Controlled Trial

Verbal numeric scale ranging from 0 to 10.0.

cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine

Qualitative variable with the following classes: obstructive pyelonephritis, hyperalgesia, urinary tract rupture, need for surgical drainage, sepsis, death

Centre Hospitalier Universitaire de Nīmes

Patients > 18 years of age with flank pain and/or costovertebral angle tenderness, documented temperature in the emergency department of ≥38°C/100.4°F by any method of measurement, and clinically suspected acute pyelonephritis. Patients will be identified by their emergency department treating physicians.

Pyelonephritis

Olive View-UCLA Medical Center

Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis

Surveillance and Risk Factor Analysis of Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis in the United States

pyelonephritis/nausea

Endothelial Dysfunction in Hyperemesis Gravidarum

Rechargeable Neurostimulators in Deep Brain Stimulation for Psychiatric Disorders

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations

Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis

科学支持的最完整的草药数据库